STUDY ON THE RATE AND SOME FACTORS ASSOCIATED WITH ACHIEVING TARGET NON-HDL CHOLESTEROL LEVELS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AT CAN THO CITY GENERAL HOSPITAL
Main Article Content
Abstract
Objectives: to investigate the rate of achieving target non-HDL cholesterol and the associated factors in patients with myocardial infarction. Materials and methods: A cross-sectional descriptive study was conducted on patients diagnosed with acute myocardial infarction who were treated at Can Tho City General Hospital from February 2025 to September 2025. All patients received treatment according to the European Society of Cardiology guidelines. After one month lipid-lowering therapy, non-HDL-c were re-evaluated, and the proportion of patients achieving target levels was recorded. Results: A total of 70 patients were enrolled, with 61.4% males. After one month treatment, the rate of achieving target non-HDL-c was 38.6%. Patients with overweight or obesity (23.1% vs. 47.7%), diabetes (20.7% vs. 51.2%), and dyslipidemia (26.5% vs. 66.7%) had lower rates of achieving target non-HDL-c levels compared with those without these conditions. Conclusion: among patients with myocardial infarction, the rate of achieving target non-HDL-c after one month was 38.6%. Patients with overweight or obesity, diabetes and dyslipidemia were less likely to achieve target non-HDL-c levels compared with those without these risk factors.
Article Details
Keywords
myocardial infarction, non-HDL-cholesterol, achievement of therapeutic targets.
References
2. Mach F, et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology and European Atherosclerosis Society. European heart journal. 2020. 41(1), p. 111-188.
3. Byrne RA, et al. ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology. European Heart Journal: Acute Cardiovascular Care. 2024. 13(1), p. 55-161.
4. Trần Thị Lượm, Nguyễn Duy Khương, Nguyễn Thành Dũng. Tình hình kiểm soát nồng độ non HDL-c huyết thanh ở bệnh nhân hội chứng vành cấp khi đơn trị atorvastatin 40mg tại Bệnh viện Đa khoa Bình Thuận năm 2024-2025. Tạp chí Y học Việt Nam. 2025. 551(1), tr. 240-244.
5. Al-Sabti H, et al. The achievement of non-high-density lipoprotein cholesterol target in patients with very high atherosclerotic cardiovascular disease risk stratified by triglyceride levels despite statin-controlled low-density lipoprotein cholesterol. Oman medical journal. 2022. 37(2), p. e367.
6. Schubert J, et al. Intensive early and sustained lowering of non–high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry. European Heart Journal. 2024. 45(39), p. 4204-4215.